Published in J Pharm Biomed Anal on August 01, 1997
Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci (2008) 4.24
"Spicing up" of the immune system by curcumin. J Clin Immunol (2007) 2.43
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther (2008) 1.86
The Essential Medicinal Chemistry of Curcumin. J Med Chem (2017) 1.68
Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med (2007) 1.51
Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro. PLoS One (2016) 1.39
Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc (2009) 1.24
Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther (2010) 1.23
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation. PPAR Res (2007) 1.19
Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem (2010) 1.13
Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin Med (2011) 1.03
Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry (2012) 1.02
Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology (2008) 1.02
Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS One (2012) 1.01
Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol (2009) 0.99
Degradation of Curcumin: From Mechanism to Biological Implications. J Agric Food Chem (2015) 0.99
Vanillin and ferulic acid: not the major degradation products of curcumin. Trends Mol Med (2012) 0.98
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol (2013) 0.97
Highly loaded, sustained-release microparticles of curcumin for chemoprevention. J Pharm Sci (2011) 0.94
Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. J Biol Chem (2015) 0.94
Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr Pharm Des (2013) 0.93
Tea polyphenols and their roles in cancer prevention and chemotherapy. Int J Mol Sci (2008) 0.91
Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons. Phytochem Rev (2014) 0.91
Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents. Drug Des Devel Ther (2014) 0.90
Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Respir Res (2015) 0.89
Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomedicine (2012) 0.87
Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food (2016) 0.87
Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting. Int J Nanomedicine (2015) 0.86
Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med (2015) 0.86
Curcumin and neurodegenerative diseases. Biofactors (2013) 0.86
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. Biomaterials (2014) 0.86
β-dicarbonyl enolates: a new class of neuroprotectants. J Neurochem (2010) 0.85
Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium. Biochem Biophys Res Commun (2011) 0.85
Stabilization of curcumin by complexation with divalent cations in glycerol/water system. Bioinorg Chem Appl (2010) 0.85
Botanical compounds: effects on major eye diseases. Evid Based Complement Alternat Med (2013) 0.84
Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation. PLoS One (2012) 0.84
Visible light and/or UVA offer a strong amplification of the anti-tumor effect of curcumin. Phytochem Rev (2013) 0.84
Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications. BMC Biotechnol (2008) 0.83
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy. Clin Ophthalmol (2012) 0.83
Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div (2015) 0.83
How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies. Sci Rep (2016) 0.83
Comparison of Antibacterial Efficacy of Calcium Hydroxide Paste, 2% Chlorhexidine Gel and Turmeric Extract as an Intracanal Medicament and their Effect on Microhardness of Root Dentin: An in vitro Study. Int J Clin Pediatr Dent (2013) 0.82
Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J Gastroenterol (2012) 0.82
Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system. AAPS J (2014) 0.82
Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells. J Mater Sci Mater Med (2015) 0.81
Oxidative Transformation of Demethoxy- and Bisdemethoxycurcumin: Products, Mechanism of Formation, and Poisoning of Human Topoisomerase IIα. Chem Res Toxicol (2015) 0.81
Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol (2010) 0.81
Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells. Oncol Lett (2012) 0.81
Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells. Int J Dev Neurosci (2011) 0.81
Effects of curcumin on Cryptosporidium parvum in vitro. Parasitol Res (2009) 0.81
Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr Pharm Des (2013) 0.80
Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol (2007) 0.80
Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects. Food Chem Toxicol (2011) 0.80
Effects of polyphenols and lipids from Pennisetum glaucum grains on T-cell activation: modulation of Ca(2+) and ERK1/ERK2 signaling. BMC Complement Altern Med (2015) 0.80
Biochemical stabilization of glucagon at alkaline pH. Diabetes Technol Ther (2014) 0.80
Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation. Int J Nanomedicine (2015) 0.79
Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm (2013) 0.79
Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats. World J Gastroenterol (2012) 0.79
Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity. Int J Nanomedicine (2014) 0.79
Curcumin-functionalized silk materials for enhancing adipogenic differentiation of bone marrow-derived human mesenchymal stem cells. Acta Biomater (2014) 0.78
Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab (2013) 0.78
Class 3 inhibition of hERG K+ channel by caffeic acid phenethyl ester (CAPE) and curcumin. Pflugers Arch (2013) 0.78
Antioxidant properties and PC12 cell protective effects of a novel curcumin analogue (2E,6E)-2,6-bis(3,5- dimethoxybenzylidene)cyclohexanone (MCH). Int J Mol Sci (2014) 0.78
Mosquitocidal properties of natural product compounds isolated from Chinese herbs and synthetic analogs of curcumin. J Med Entomol (2012) 0.78
Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance. ACS Med Chem Lett (2012) 0.78
Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies. J Am Coll Nutr (2015) 0.78
Capping of aβ42 oligomers by small molecule inhibitors. Biochemistry (2014) 0.78
Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats. Genes Nutr (2016) 0.78
Bioavailability of a lipidic formulation of curcumin in healthy human volunteers. Pharmaceutics (2012) 0.77
Destabilization Mechanism of Ionic Surfactant on Curcumin Nanocrystal against Electrolytes. Sci Pharm (2016) 0.77
Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. Eur J Med Chem (2015) 0.77
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study. Clin Ophthalmol (2013) 0.77
C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis. Biosci Rep (2016) 0.77
Discovery of a new function of curcumin which enhances its anticancer therapeutic potency. Sci Rep (2016) 0.77
Fabrication and Evaluation of Curcumin-loaded Nanoparticles Based on Solid Lipid as a New Type of Colloidal Drug Delivery System. Indian J Pharm Sci (2013) 0.77
Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. Biomed Res Int (2015) 0.76
The circadian clock modulates anti-cancer properties of curcumin. BMC Cancer (2016) 0.76
A novel, stable, aqueous glucagon formulation using ferulic acid as an excipient. J Diabetes Sci Technol (2014) 0.76
Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity. Sci Rep (2016) 0.76
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors. ACS Med Chem Lett (2013) 0.76
A novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles/polymersomes for curcumin delivery to cancer cells. Int J Nanomedicine (2014) 0.76
Antioxidant potential of curcumin-related compounds studied by chemiluminescence kinetics, chain-breaking efficiencies, scavenging activity (ORAC) and DFT calculations. Beilstein J Org Chem (2015) 0.76
Active curcumin nanoparticles formed from a volatile microemulsion template. J Mater Chem B Mater Biol Med (2014) 0.76
Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy. Int J Nanomedicine (2017) 0.75
Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties. Int J Nanomedicine (2015) 0.75
Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin. Sci Rep (2016) 0.75
Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PLoS One (2014) 0.75
Two Traditional Chinese Medicines Curcumae Radix and Curcumae Rhizoma: An Ethnopharmacology, Phytochemistry, and Pharmacology Review. Evid Based Complement Alternat Med (2016) 0.75
Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system. World J Gastrointest Oncol (2016) 0.75
Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity. AAPS PharmSciTech (2015) 0.75
Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers. Front Pharmacol (2016) 0.75
Studies to reveal the nature of interactions between catalase and curcumin using computational methods and optical techniques. Int J Biol Macromol (2016) 0.75
The Nutraceutical Dehydrozingerone and Its Dimer Counteract Inflammation- and Oxidative Stress-Induced Dysfunction of In Vitro Cultured Human Endothelial Cells: A Novel Perspective for the Prevention and Therapy of Atherosclerosis. Oxid Med Cell Longev (2016) 0.75
Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers. Bioorg Med Chem Lett (2013) 0.75
Oxidative metabolism of curcumin-glucuronide by peroxidases and isolated human leukocytes. Biochem Pharmacol (2017) 0.75
N-succinyl chitosan-dialdehyde starch hybrid hydrogels for biomedical applications. J Adv Res (2015) 0.75
A comparative study of nutmeg (Myristica fragrans Houtt.) oleoresins obtained by conventional and green extraction techniques. J Food Sci Technol (2016) 0.75
Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria. J Nanobiotechnology (2016) 0.75
A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles. AAPS J (2016) 0.75
A Realistic View on "The Essential Medicinal Chemistry of Curcumin". ACS Med Chem Lett (2017) 0.75
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res (2001) 5.78
The use of pKc30 and its derivatives for controlled expression of genes. Methods Enzymol (1983) 3.90
Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos (1999) 3.30
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho. Proc Natl Acad Sci U S A (1985) 2.70
Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol (2001) 2.38
Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood (2000) 2.19
Bacteriophage lambda protein cII binds promoters on the opposite face of the DNA helix from RNA polymerase. Nature (1983) 2.13
The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest (1996) 2.07
Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function. Virology (1982) 1.99
Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol (1998) 1.95
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys (2000) 1.89
2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res (1977) 1.88
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet (1999) 1.86
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys (2001) 1.76
Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol (2000) 1.74
Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol (1998) 1.72
Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol (1999) 1.72
Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer (1999) 1.68
Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res (1977) 1.67
Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis (1999) 1.67
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J Mol Cell Cardiol (2001) 1.65
(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol (1997) 1.55
Local thermal stimulation relaxes hypertonic anal sphincter: evidence of somatoanal reflex. Dis Colon Rectum (1999) 1.54
Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci U S A (1991) 1.53
Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience (2000) 1.53
Chromophoric labeling of amino acids with 4-dimethylaminoazobenzene-4'-sulfonyl chloride. Anal Chem (1975) 1.50
Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol (2000) 1.48
Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores? J Manipulative Physiol Ther (2000) 1.46
Left atrial ball thrombus in nonrheumatic atrial fibrillation diagnosed by transesophageal echocardiography. Am Heart J (1992) 1.46
Urinary excretion of paranitrophenol and alkyl phosphates following ingestion of methyl or ethyl parathion by human subjects. Arch Environ Contam Toxicol (1977) 1.45
Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients. Gynecol Oncol (1998) 1.42
The role of blocking factors and antipaternal lymphocytotoxic antibodies in the success of pregnancy in patients with recurrent spontaneous abortion. Fertil Steril (1992) 1.41
Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem (2000) 1.40
The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene (2001) 1.39
Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice. J Assoc Res Otolaryngol (2000) 1.39
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis (2000) 1.34
Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem (1999) 1.34
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta (1996) 1.33
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem (1997) 1.32
Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc Natl Acad Sci U S A (1992) 1.31
Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid (1999) 1.30
L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen. Am J Pathol (1986) 1.29
Glutathione peroxidase-1 deficiency leads to increased nuclear light scattering, membrane damage, and cataract formation in gene-knockout mice. Invest Ophthalmol Vis Sci (2001) 1.29
Morbidity and mortality in workers occupationally exposed to pesticides. Arch Environ Contam Toxicol (1980) 1.28
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Human Gi protein alpha-subunit: deduction of amino acid structure from a cloned cDNA. FEBS Lett (1987) 1.25
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer (1997) 1.24
Unique features of breast cancer in Taiwan. Breast Cancer Res Treat (2000) 1.23
Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology (1999) 1.23
Removal of Cr(VI) from aqueous solutions using agricultural waste 'maize bran'. J Hazard Mater (2007) 1.23
In vivo aminoacylation of human and Xenopus suppressor tRNAs constructed by site-specific mutagenesis. Proc Natl Acad Sci U S A (1987) 1.22
H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation (2001) 1.20
Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol (2000) 1.20
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett (2001) 1.20
Cellular glutathione peroxidase knockout mice express normal levels of selenium-dependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J Nutr (1997) 1.20
Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis (2008) 1.20
Characterization of a third, cII-dependent, coordinately activated promoter on phage lambda involved in lysogenic development. J Biol Chem (1985) 1.20
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg (2003) 1.19
cDNA and deduced amino acid sequence of rat copper-zinc-containing superoxide dismutase. Nucleic Acids Res (1987) 1.19
Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab (2000) 1.18
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr (1998) 1.16
Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis (2001) 1.14
Clinical and pathological characteristics of secondary thyroid cancer. Thyroid (1998) 1.14
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer (1996) 1.14
Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler Thromb Vasc Biol (2001) 1.14
Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J Neurosci (1999) 1.13
Cell type-specific protein-DNA interactions in the human zeta-globin upstream promoter region: displacement of Sp1 by the erythroid cell-specific factor NF-E1. Mol Cell Biol (1990) 1.13
The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys (1997) 1.12
Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol (1994) 1.11
Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg (1995) 1.10
Trend of large bowel tuberculosis and the relation with pulmonary tuberculosis. Dis Colon Rectum (1992) 1.10
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma (1995) 1.10
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol (2001) 1.10
Nasopharyngeal Castleman's disease. J Formos Med Assoc (1996) 1.09
Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival. Oncology (1999) 1.09
Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer (2001) 1.08
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. Anticancer Res (2000) 1.08
Experimental focal segmental glomerulosclerosis in mice. Nephron (1998) 1.08
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition. Oncology (1997) 1.07
Primary cardiac chondrosarcoma. Am J Emerg Med (1996) 1.07
Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol (2000) 1.06
Enterovesical fistula: 10 years experience. Zhonghua Yi Xue Za Zhi (Taipei) (1997) 1.06
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer (1998) 1.06
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol (2000) 1.06
Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes. J Am Acad Dermatol (1990) 1.04
Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer (2000) 1.04
A prospective randomized three-week trial of spinal manipulation, transcutaneous muscle stimulation, massage and corset in the treatment of subacute low back pain. Spine (Phila Pa 1976) (1994) 1.04
Spinal extradural cavernous hemangioma. Surg Neurol (1990) 1.03
A critical period for nicotine-induced disruption of synaptic development in rat auditory cortex. J Neurosci (2000) 1.03